If B is proven to be as effective in moderate to severe COVID patients as it was in preclinicals, what does everyone think happens next? Does B get bought by by a large pharma or do we partner with a large pharma to take us through the next steps? Do we pursue EUA on our own? Does Leo plan to sell the entire pipeline or only B and then continue to develop K? I recall Leo indicating that after phase II is where most deals are made. I am sure there are many other options that Leo could be working on currently not to mention that certain governments may want to purchase large amounts of B (see Merck article today). We are only weeks away from results so whatever might happen could happen quickly.